On September 20, 2023, Becton, Dickinson and Company (NYSE:BDX) released its latest stock report, providing an update on its quarterly earnings and recent business transactions. The medical instruments supplier reported an EPS of $2.96 for the quarter, surpassing analysts’ consensus estimates of $2.89 by $0.07. This performance demonstrates the company’s ability to generate strong revenue and deliver value to its shareholders.
Becton, Dickinson and Company achieved a net margin of 8.73% and a return on equity of 13.24%. These figures indicate the company’s efficiency in managing costs while maximizing its profitability. With revenue amounting to $4.88 billion for the quarter, Becton, Dickinson and Company exceeded analyst estimates of $4.84 billion. This represents a positive growth rate of 5.1% compared to the same period last year when the firm earned $2.66 per share.
In terms of recent stock transactions, Executive Vice President (EVP) Michael David Garrison sold 1,300 shares of the company’s stock on August 8th at an average price of $277.13, resulting in a total value of $360,269.00. Following this sale, Garrison now holds 5,157 shares in Becton, Dickinson and Company with an estimated value of $1,429,159.41.
Additionally, EVP David Hickey sold 2,974 shares on August 11th at an average price of $277.85—totaling a value of $826,325.90—bringing his holdings down to 4,199 shares valued at approximately $1,166,692.15.
These insider sales were disclosed through filings with the Securities & Exchange Commission (SEC), which can be accessed via their official website.
It is worth noting that in total, insiders have sold 5,581 shares of Becton, Dickinson and Company stock in the last quarter, with a combined worth of $1,551,429. Corporate insiders currently own 0.31% of the company’s stock.
The disclosure of these transactions demonstrates the confidence that company executives have in its financial performance and future prospects. Shareholders can take this as a positive sign that the company is on track to deliver sustainable growth and value.
Becton, Dickinson and Company’s ability to exceed earnings expectations and maintain a healthy financial position indicates its strong market presence within the medical instruments industry. Investors and stakeholders can continue to monitor the company’s progress as it moves forward with its strategic endeavors to drive innovation and capture market opportunities.
Becton, Dickinson and Company
BDX
Strong Buy
Updated on: 02/12/2023
Financial Health
Very Healthy
Debt to equity ratio: Buy
Price to earnings ratio: Strong Buy
Price to book ratio: Strong Buy
DCF: Strong Buy
ROE: Neutral
Zacks Research Raises Q1 Earnings Estimates for Becton, Dickinson and Company
September 20, 2023
Intriguing Q1 Earnings Estimates for Becton, Dickinson and Company Released by Zacks Research
Becton, Dickinson and Company (NYSE:BDX), a leading medical instruments supplier, has recently been the subject of attention from analysts at Zacks Research. These analysts have raised their earnings estimates for the company’s Q1 2024 financial results. In a research report issued on Tuesday, September 19th, Zacks Research analyst D. Dey now predicts that Becton, Dickinson and Company will post earnings per share of $3.03 for the quarter. This is an increase from their prior forecast of $3.02.
Furthermore, Zacks Research also provided estimates for Becton, Dickinson and Company’s other financial periods. They projected Q4 2024 earnings to be $3.89 EPS and FY2024 to reach $13.34 EPS. Additionally, they estimated that Q3 2025 earnings will be $3.87 EPS.
Other market research analysts have also recently published reports concerning Becton, Dickinson and Company’s stock performance. Barclays raised their price objective on the company’s shares from $284.00 to $303.00 while providing an “overweight” rating on Monday, August 7th. On Wednesday, August 16th, StockNews.com downgraded Becton, Dickinson and Company from a “buy” rating to a “hold” rating in their research note. Raymond James lowered their price objective on the stock from $305.00 to $304.00 but maintained an “outperform” rating on Friday, August 4th.
Citigroup raised its price objective on shares of Becton, Dickinson and Company from $260.00 to $282.00 and gave the stock a “neutral” rating in its research note released on Monday, August 21st. Eventually, Morgan Stanley raised their price objective to $310.00 and gave the stock an “overweight” rating in their research note on Friday, August 4th.
Based on data from Bloomberg, Becton, Dickinson and Company currently holds a consensus rating of “Moderate Buy,” with an average target price of $288.44.
In other news, EVP Michael David Garrison recently sold 1,300 shares of the company’s stock in a transaction that took place on Tuesday, August 8th. The shares were sold at an average price of $277.13 per share, amounting to a total value of $360,269.00. Following this sale, the executive vice president now owns 5,157 shares in the company, valued at approximately $1,429,159.41.
Similarly, EVP David Hickey sold 2,974 shares of Becton, Dickinson and Company’s stock in a transaction on Friday, August 11th. The average selling price was $277.85 per share for a total value of $826,325.90. Currently holding 4,199 shares in the company after the sale concluded – valued at approximately $1,166,692.15 – is the executive vice president.
These sales were disclosed in filings with the Securities & Exchange Commission (SEC), which can be accessed through the SEC website.
Corporate insiders have been active sellers over recent months according to SEC filings reports. In total during Q3 2023 insiders thus far have sold off roughly 5k shares valued at around $1.6m or about roughly .31% of outstanding ownership capitalization across all classes.
On Wednesday (20Sep23), Becton Dickinson started trading at $265.96 on NYSE (New York Stock Exchange). The company’s current full-year earnings average estimate is set at $12.23 per share as of now. The firm has a market capitalization of $77.16 billion, and its price-to-earnings ratio stands at 48.27. It also has a P/E/G ratio of 2.19 and a beta of 0.57. The company boasts a quick ratio of 0.73, a current ratio of 1.25, and a debt-to-equity ratio of 0.58.
Over the last twelve months, Becton, Dickinson and Company has witnessed its share prices fluctuate between $215.90 – $287.32.
Several institutional investors have made notable changes to their positions in Becton, Dickinson and Company recently as well. McClarren Financial Advisors Inc., for example, raised its holdings by an impressive 4,900%, now owning 100 shares valued at $26,000 after purchasing an additional 98 shares during the last quarter.
Another institutional investor experiencing growth is Heritage Wealth Management LLC with holdings that increased by approximately 152.4% in the fourth quarter to keep pace with changing market trends.
Additionally, several other institutions such as OLD Point Trust & Financial Services N A, Glass Jacobson Investment Advisors llc, and CGC Financial Services LLC have contributed by acquiring new positions or adding more
Discussion about this post